- Report
- March 2025
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- December 2024
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- November 2024
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- September 2024
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- April 2024
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- January 2024
- 150 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Report
- September 2025
- 373 Pages
Europe
From €5541EUR$5,995USD£4,619GBP
- Report
- September 2025
- 435 Pages
North America
From €5541EUR$5,995USD£4,619GBP
- Report
- September 2025
- 472 Pages
Asia Pacific
From €5541EUR$5,995USD£4,619GBP
- Report
- June 2025
- 59 Pages
Global
From €9238EUR$9,995USD£7,701GBP
- Report
- June 2025
- 158 Pages
Canada
From €4617EUR$4,995USD£3,849GBP
- Report
- June 2025
- 147 Pages
Germany
From €4617EUR$4,995USD£3,849GBP
- Report
- June 2025
- 141 Pages
India
From €4617EUR$4,995USD£3,849GBP
- Report
- June 2025
- 161 Pages
Australia
From €4617EUR$4,995USD£3,849GBP
- Report
- April 2025
- 15 Pages
Global
From €9238EUR$9,995USD£7,701GBP
- Clinical Trials
- March 2025
- 490 Pages
Global
From €3189EUR$3,450USD£2,658GBP
- Report
- December 2024
- 55 Pages
Global
From €2310EUR$2,499USD£1,925GBP
- Report
- October 2024
- 159 Pages
Global
From €3697EUR$4,000USD£3,082GBP
- Report
- September 2024
- 115 Pages
Global
From €3697EUR$4,000USD£3,082GBP
- Drug Pipelines
- January 2023
- 33 Pages
Global
From €9238EUR$9,995USD£7,701GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more